Epicardial fat as a predictor of COVID-19 disease severity: Just a surrogate for obesity or a true independent predictor?
作者信息
Strong Christopher
机构信息
Serviço de Cardiologia, CHLO, Hospital de Santa Cruz, Carnaxide, Portugal.
出版信息
Rev Port Cardiol. 2022 Sep;41(9):739-740. doi: 10.1016/j.repc.2022.07.004. Epub 2022 Jul 18.
Abstract
摘要
相似文献
1
Epicardial fat as a predictor of COVID-19 disease severity: Just a surrogate for obesity or a true independent predictor?心外膜脂肪作为COVID-19疾病严重程度的预测指标：仅仅是肥胖的替代指标还是真正的独立预测指标？
Rev Port Cardiol. 2022 Sep;41(9):739-740. doi: 10.1016/j.repc.2022.07.004. Epub 2022 Jul 18.
2
Higher ACE2 expression levels in epicardial cells than subcutaneous stromal cells from patients with cardiovascular disease: Diabetes and obesity as possible enhancer.心肌细胞中 ACE2 表达水平高于心血管疾病患者的皮下基质细胞：糖尿病和肥胖可能是增强因子。
Eur J Clin Invest. 2021 May;51(5):e13463. doi: 10.1111/eci.13463. Epub 2020 Dec 14.
3
Epicardial adipose tissue measured from analysis of adipose tissue area using chest CT imaging is the best potential predictor of COVID-19 severity.通过胸部CT成像分析脂肪组织面积测得的 epicardial 脂肪组织是 COVID-19 严重程度的最佳潜在预测指标。
Metabolism. 2024 Jan;150:155715. doi: 10.1016/j.metabol.2023.155715. Epub 2023 Oct 31.
4
Epicardial fat, cardiac dimensions, and low-grade inflammation in young adult monozygotic twins discordant for obesity.心外膜脂肪、心脏结构和肥胖不一致的年轻成年单卵双胞胎的低度炎症。
Am J Cardiol. 2012 May 1;109(9):1295-302. doi: 10.1016/j.amjcard.2011.12.023. Epub 2012 Feb 10.
5
Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects.肥胖人群的心外膜脂肪厚度与非酒精性脂肪肝。
Obesity (Silver Spring). 2014 Feb;22(2):332-6. doi: 10.1002/oby.20624. Epub 2013 Oct 17.
6
The ratio of epicardial to body fat improves the prediction of coronary artery disease beyond calcium and Framingham risk scores.心外膜脂肪与体脂的比例，相比钙化积分和弗雷明汉风险评分，能更好地预测冠状动脉疾病。
Int J Cardiovasc Imaging. 2016 Jun;32 Suppl 1:117-27. doi: 10.1007/s10554-016-0912-2. Epub 2016 Jun 13.
7
Association of epicardial fat thickness with clinical and polysomnographic parameters in non-obese obstructive sleep apnoea patients.非肥胖阻塞性睡眠呼吸暂停患者的心外膜脂肪厚度与临床和多导睡眠图参数的相关性
J Laryngol Otol. 2018 May;132(5):439-445. doi: 10.1017/S0022215118000579. Epub 2018 Apr 23.
8
Epicardial fat, rather than pericardial fat, is independently associated with diastolic filling in subjects without apparent heart disease.在心外膜脂肪而非心包脂肪与无明显心脏病患者的舒张期充盈独立相关。
Nutr Metab Cardiovasc Dis. 2014 Aug;24(8):877-82. doi: 10.1016/j.numecd.2014.01.019. Epub 2014 Feb 12.
9
The predictive value of epicardial fat volume for clinical severity of COVID-19.心外膜脂肪体积对新型冠状病毒肺炎临床严重程度的预测价值。
Rev Port Cardiol. 2022 Sep;41(9):729-737. doi: 10.1016/j.repc.2021.05.016. Epub 2022 Apr 29.
10
Epicardial fat thickness: A surrogate marker of coronary artery disease - Assessment by echocardiography.心外膜脂肪厚度：冠状动脉疾病的替代标志物——经超声心动图评估
Indian Heart J. 2016 May-Jun;68(3):336-41. doi: 10.1016/j.ihj.2015.08.005. Epub 2016 Jan 18.
本文引用的文献
1
The predictive value of epicardial fat volume for clinical severity of COVID-19.心外膜脂肪体积对新型冠状病毒肺炎临床严重程度的预测价值。
Rev Port Cardiol. 2022 Sep;41(9):729-737. doi: 10.1016/j.repc.2021.05.016. Epub 2022 Apr 29.
2
Epicardial adipose tissue thickness is associated with increased COVID-19 severity and mortality.心外膜脂肪组织厚度与 COVID-19 严重程度和死亡率的增加有关。
Int J Obes (Lond). 2022 Apr;46(4):866-873. doi: 10.1038/s41366-021-01050-7. Epub 2022 Jan 11.
3
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis.欧洲心脏病学会在 COVID-19 大流行期间心血管疾病的诊断和管理指南：第 1 部分-流行病学、病理生理学和诊断。
Cardiovasc Res. 2022 May 6;118(6):1385-1412. doi: 10.1093/cvr/cvab342.
4
The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States.疫苗接种对美国 2019 年冠状病毒病（COVID-19）疫情爆发的影响。
Clin Infect Dis. 2021 Dec 16;73(12):2257-2264. doi: 10.1093/cid/ciab079.
5
Obesity and COVID-19: A jigsaw puzzle with still missing pieces.肥胖与 COVID-19：一块仍缺失部分的拼图。
Clin Obes. 2021 Feb;11(1):e12420. doi: 10.1111/cob.12420. Epub 2020 Oct 18.
6
Obesity in patients with COVID-19: a systematic review and meta-analysis.COVID-19 患者中的肥胖症：系统评价和荟萃分析。
Metabolism. 2020 Dec;113:154378. doi: 10.1016/j.metabol.2020.154378. Epub 2020 Sep 28.
7
Does epicardial fat contribute to COVID-19 myocardial inflammation?心外膜脂肪会导致新型冠状病毒肺炎心肌炎症吗？
Eur Heart J. 2020 Jun 21;41(24):2333. doi: 10.1093/eurheartj/ehaa471.
8
Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes.肥胖与 COVID-19：免疫和代谢紊乱可能是导致不良临床结局的原因之一。
Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E105-E109. doi: 10.1152/ajpendo.00198.2020. Epub 2020 May 27.
9
Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium.心外膜脂肪组织可能介导肥胖和炎症对心肌的有害影响。
J Am Coll Cardiol. 2018 May 22;71(20):2360-2372. doi: 10.1016/j.jacc.2018.03.509.
Zotero 插件